Ascend Laboratories, LLC recalls
10 recalls.
- Amlodipine and Olmesartan Medoxomil Tablets recall (Ascend Laboratories, LLC)
DrugClass IIReported October 28, 2026 · Out of specification due to dissolution. - Dabigatran Etexilate Capsules recall (Ascend Laboratories, LLC)
DrugClass IIIReported August 5, 2026 · Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for... - Dabigatran Etexilate Capsules recall (Ascend Laboratories, LLC)
DrugClass IIIReported August 5, 2026 · Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for... - Dabigatran Etexilate Capsules recall (Ascend Laboratories, LLC)
DrugClass IIIReported August 5, 2026 · Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for... - Dabigatran etexilate Capsules recall (Ascend Laboratories, LLC)
DrugClass IIIReported July 29, 2026 · Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and... - Dabigatran etexilate Capsules recall (Ascend Laboratories, LLC)
DrugClass IIIReported July 29, 2026 · Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and... - Amlodipine and Olmesartan Medoxomil Tablets recall (Ascend Laboratories, LLC)
DrugClass IIReported July 29, 2026 · Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications - Minocycline Hydrochloride Extended-Release Tablets recall (Ascend Laboratories, LLC)
DrugClass IIReported June 17, 2026 · Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis - Amlodipine and Olmesartan Medoxomil Tablets recall (Ascend Laboratories, LLC)
DrugClass IIReported June 10, 2026 · Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications - Ascend Laboratories recall (Ascend Laboratories, LLC)
DrugClass IIReported May 20, 2026 · Failed Dissolution Specifications